Determination of autoantibodies to pancreatic antigens in patients with type 1 diabetes mellitus and children from risk groups
https://doi.org/10.14341/probl11845
Abstract
Methodological aspects of immunofluorescent detection of autoantibodies to Langerhans' islet /З-cell antigens (ICA), a marker indicating early preclinical insulin-dependent diabetes mellitus (IDDM), have been modified and standardized. The distribution and levels of ICA were evaluated in patients with first diagnosed IDDM and their relatives (risk group) (total 298). In patients with newly diagnosed IDDM, ICA were detected in 83.3% cases. 15.4% clinically healthy siblings of IDDMpatients and 8.3% children one of whose parents was a diabetic were ICA-positive. About 16% children with non-IDDM carbohydrate metabolism disorders were ICA-positive. Hence, immunofluorescent detection of ICA helps detect this IDDM marker; the process is to be monitored in high-risk children and they should be prescribed therapeutic and prophylactic agents preventing the progress of diabetes.
About the Authors
N. L. VartanyanResearch Institute of Influenza RAMS
Russian Federation
A. A. Sominina
Research Institute of Influenza RAMS
Russian Federation
V. V. Zarubaev
Research Institute of Influenza RAMS
Russian Federation
A. S. Stroykova
Research Institute of Influenza RAMS
Russian Federation
I. N. Ostretsova
Research Institute of Influenza RAMS
Russian Federation
O. I. Kiselev
Research Institute of Influenza RAMS
Russian Federation
References
1. Bonifacio Е., Boitard С., Gleichman Н. et al. // Diabetologia. — 1990. Vol. 33, N 12. P. 731-736.
2. Bonifacio E.. Genovese S., Braghi S. et al. // Ibid. — 1995. — Vol. 38, N 7. P. 816-822.
3. Bonifacio E., Bingley P. J. // Acta Diabetol. — 1997. — Vol. 34, N 3. P. 185-193.
4. Bottazzo G. F. Florin-Christensen A., Doniach D. // Lancet. — 1974. Vol. 2, N 7892. P. 1279-1282.
5. Karjalainen J. K. // Diabetes. — 1990. — Vol. 39. N 9. — P. 1144-1150.
6. Knip M., Vcihiisalo P., Karjalainen J. et al. // Diabetologia. — 1994. Vol. 37, N 4. P. 388-393.
7. Kulmala P., Savoia K., Petersen J. S. et al. // J. Clin. Invest. — 1998. Vol. 101, N 2. P. 327-336.
8. Lernmark A., Molenaar I. L., van Beers W. A. M. et al. // Diabetologia. — 1991. — Vol. 34, N 7. — P. 534—535.
9. Lorenzen T., Pociot E, Hougaard P., Nerup J. // Ibid. — 1994. — Vol. 37, N 3. P. 321-327.
10. Marner B., Lernmark A., Nerup J. et al. // ibid. — 1983. — Vol. 25, N 2. P. 93-96.
11. Pozzilli PI I Diabet. Metab. Rev. — 1998. — Vol. 14, N I. P. 69-84.
12. Riley W. J., Maclaren N. K.. Krischer J. et al. // N. Engl. J. Med. 1990. Vol. 323, N 17. P. 1167-1172.
13. Schatz D., Krischer J., Horne G. et al. // J. Clin. Invest. — 1994. Vol. 93, N 10. P. 2403-2407.
14. Schranz D. B., Lernmark A. // Diabet. Metab. Rev. — 1998. — Vol. 14, N 1. P. 3-29.
15. Vdhasalo P., Knip M., Karjalainen J. // Enr. J. Endocrinol. — Vol. 135, N 6. P. 689-695.
Review
For citations:
Vartanyan N.L., Sominina A.A., Zarubaev V.V., Stroykova A.S., Ostretsova I.N., Kiselev O.I. Determination of autoantibodies to pancreatic antigens in patients with type 1 diabetes mellitus and children from risk groups. Problems of Endocrinology. 2000;46(3):3-7. (In Russ.) https://doi.org/10.14341/probl11845
Views:
927
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
